RNA Covid vaccine was initially 'developed for oncology use and was already in phase 2'

A brand new remedy practically halves the danger of illness development or demise from a much less frequent type of breast most cancers that hasn’t seen main drug advances in over a decade, Outcomes from the research, offered on the annual assembly of the American Society for Scientific Oncology and will quickly set up a brand new first-line remedy for individuals with HER2-positive metastatic breast most cancers. In the meantime, researchers are combining RNA and AI to develop tailored vaccines to fight most cancers. For a deeper understanding of latest technological breakthroughs in drugs, FRANCE 24’s François Picard welcomes Dr. Moez Benali (MD, PhD), Senior Medical Director at Fortrea. Dr Benali is a member of Fortrea’s world medical staff and presently heads Oncologues Sans Frontières.



Source link